🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ARCH is a randomised, stratified, multicentre, phase III trial. Protocol tr...
Status
Recruiting
Location
Wien AKH
Start Date
2026-01-12
Trial ID
NCT06931717
Treatments Being Tested
This is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose ...
Status
Recruiting
Location
Site-111
Start Date
2025-03-20
Trial ID
NCT06874335
Treatments Being Tested
This is a phase II, randomized study which will enroll participants given 4...
Status
Not Yet Recruiting
Location
Hospital Israelita Albert Einstein
Start Date
2025-12
Trial ID
NCT07101822
Treatments Being Tested
The primary purpose of this research study is to test the safety and possib...
Status
Withdrawn
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-07
Trial ID
NCT05729139
Treatments Being Tested
THIO is a first-in-class small molecule telomere targeting agent, in develo...
Status
Active Not Recruiting
Location
Central Alabama Research
Start Date
2022-06-08
Trial ID
NCT05208944
Treatments Being Tested
This is a phase II, randomized study that will include 42 participants who ...
Status
Not Yet Recruiting
Location
Hospital Israelita Albert Einstein
Start Date
2025-11-01
Trial ID
NCT07101848
Treatments Being Tested
This is an open-label, multicenter, first-in-human dose-escalation and expa...
Status
Unknown
Location
HonorHealth Research Institute
Start Date
2021-09-09
Trial ID
NCT05094804
Treatments Being Tested
Primary Objectives: Phase 1 -To characterize the safety and tolerability ...
Status
Terminated
Location
Investigational Site Number :2500005
Start Date
2018-12-11
Trial ID
NCT03769181
Treatments Being Tested
This phase 1b/2a study evaluates the safety, feasibility, and efficacy of c...
Status
Recruiting
Location
CHUM
Start Date
2025-08-19
Trial ID
NCT06743581
Treatments Being Tested
This is a single-arm, open-label, phase 2 study that will enroll 36 subject...
Status
Active Not Recruiting
Location
Froedtert Hospital & Medical College of Wisconsin
Start Date
2020-03-05
Trial ID
NCT04243616
Treatments Being Tested